

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.87499624 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.78680775 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.55443012 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55443012 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.26782983 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26782983 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.88004108 |
| 8 | oxidative demethylation (GO:0070989) | 6.51649011 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.27756933 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.27756933 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.27756933 |
| 12 | glyoxylate metabolic process (GO:0046487) | 6.08132738 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.03505060 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.91599391 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 5.87908822 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.87898927 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.82312615 |
| 18 | cysteine metabolic process (GO:0006534) | 5.71018922 |
| 19 | phenylpropanoid metabolic process (GO:0009698) | 5.58845374 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44344506 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.39115652 |
| 22 | urea cycle (GO:0000050) | 5.39004936 |
| 23 | urea metabolic process (GO:0019627) | 5.39004936 |
| 24 | regulation of plasminogen activation (GO:0010755) | 5.30465102 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.29586959 |
| 26 | ethanol metabolic process (GO:0006067) | 5.27554714 |
| 27 | lysine catabolic process (GO:0006554) | 5.25248769 |
| 28 | lysine metabolic process (GO:0006553) | 5.25248769 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 5.17056763 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 5.13801269 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.09855313 |
| 32 | protein carboxylation (GO:0018214) | 5.04313518 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04313518 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 5.01482382 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.97921793 |
| 36 | S-adenosylmethionine metabolic process (GO:0046500) | 4.97483203 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.97223042 |
| 38 | bile acid metabolic process (GO:0008206) | 4.95977857 |
| 39 | protein activation cascade (GO:0072376) | 4.93479655 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.92795980 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.92727291 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.92403484 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.92403484 |
| 44 | alkaloid metabolic process (GO:0009820) | 4.88716420 |
| 45 | regulation of protein activation cascade (GO:2000257) | 4.86326770 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.76566671 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.72551973 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.69138582 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.69053844 |
| 50 | complement activation (GO:0006956) | 4.62817969 |
| 51 | acute-phase response (GO:0006953) | 4.56928203 |
| 52 | complement activation, classical pathway (GO:0006958) | 4.56572628 |
| 53 | regulation of complement activation (GO:0030449) | 4.54538631 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 4.53960116 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.50745519 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.50745519 |
| 57 | regulation of cholesterol esterification (GO:0010872) | 4.48893456 |
| 58 | reverse cholesterol transport (GO:0043691) | 4.48524494 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.47664531 |
| 60 | drug catabolic process (GO:0042737) | 4.46511551 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.45119853 |
| 62 | regulation of humoral immune response (GO:0002920) | 4.43374819 |
| 63 | negative regulation of wound healing (GO:0061045) | 4.40924044 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 4.40585525 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 4.40362833 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 4.39719443 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 4.39719443 |
| 68 | macromolecular complex remodeling (GO:0034367) | 4.39719443 |
| 69 | glutamate metabolic process (GO:0006536) | 4.37987405 |
| 70 | acylglycerol homeostasis (GO:0055090) | 4.37117450 |
| 71 | triglyceride homeostasis (GO:0070328) | 4.37117450 |
| 72 | glycine metabolic process (GO:0006544) | 4.36245006 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.34204741 |
| 74 | cellular glucuronidation (GO:0052695) | 4.33245325 |
| 75 | amine catabolic process (GO:0009310) | 4.32517561 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.32517561 |
| 77 | coenzyme catabolic process (GO:0009109) | 4.31474654 |
| 78 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.30837524 |
| 79 | opsonization (GO:0008228) | 4.27213575 |
| 80 | urate metabolic process (GO:0046415) | 4.26548826 |
| 81 | positive regulation of blood coagulation (GO:0030194) | 4.26256247 |
| 82 | positive regulation of hemostasis (GO:1900048) | 4.26256247 |
| 83 | bile acid and bile salt transport (GO:0015721) | 4.24407604 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 4.23903035 |
| 85 | negative regulation of protein activation cascade (GO:2000258) | 4.23463318 |
| 86 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.20090172 |
| 87 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.20090172 |
| 88 | phospholipid efflux (GO:0033700) | 4.19336562 |
| 89 | ethanol oxidation (GO:0006069) | 4.16414275 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 4.13145048 |
| 91 | short-chain fatty acid metabolic process (GO:0046459) | 4.09049709 |
| 92 | ketone body metabolic process (GO:1902224) | 4.06012107 |
| 93 | hormone catabolic process (GO:0042447) | 4.04668282 |
| 94 | plasma lipoprotein particle clearance (GO:0034381) | 4.02910171 |
| 95 | aldehyde catabolic process (GO:0046185) | 4.02842878 |
| 96 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02361995 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 4.01599148 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.99599282 |
| 99 | cytolysis (GO:0019835) | 3.99443138 |
| 100 | positive regulation of coagulation (GO:0050820) | 3.94689922 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.92342126 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.92342126 |
| 103 | arginine metabolic process (GO:0006525) | 3.89532480 |
| 104 | * drug transmembrane transport (GO:0006855) | 3.89064361 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.88933181 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.88212282 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.87611979 |
| 108 | organic acid catabolic process (GO:0016054) | 3.87611979 |
| 109 | intestinal cholesterol absorption (GO:0030299) | 3.86364580 |
| 110 | cholesterol efflux (GO:0033344) | 3.86273314 |
| 111 | response to mercury ion (GO:0046689) | 3.86251499 |
| 112 | aspartate family amino acid catabolic process (GO:0009068) | 3.83270694 |
| 113 | heme transport (GO:0015886) | 3.80046066 |
| 114 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.77892576 |
| 115 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72414026 |
| 116 | fibrinolysis (GO:0042730) | 3.71260437 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 3.70488665 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70083695 |
| 119 | flavonoid metabolic process (GO:0009812) | 3.67948603 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 3.65825060 |
| 121 | polyketide metabolic process (GO:0030638) | 3.64508834 |
| 122 | doxorubicin metabolic process (GO:0044598) | 3.64508834 |
| 123 | daunorubicin metabolic process (GO:0044597) | 3.64508834 |
| 124 | low-density lipoprotein particle remodeling (GO:0034374) | 3.64043432 |
| 125 | cofactor catabolic process (GO:0051187) | 3.63013647 |
| 126 | xenobiotic metabolic process (GO:0006805) | 3.62926845 |
| 127 | steroid catabolic process (GO:0006706) | 3.62415414 |
| 128 | fatty acid oxidation (GO:0019395) | 3.61234763 |
| 129 | fatty acid beta-oxidation (GO:0006635) | 3.59991369 |
| 130 | monocarboxylic acid catabolic process (GO:0072329) | 3.59178260 |
| 131 | cholesterol homeostasis (GO:0042632) | 3.58249864 |
| 132 | drug metabolic process (GO:0017144) | 3.58173905 |
| 133 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56915015 |
| 134 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56915015 |
| 135 | carnitine metabolic process (GO:0009437) | 3.55648940 |
| 136 | phospholipid homeostasis (GO:0055091) | 3.55068461 |
| 137 | sterol homeostasis (GO:0055092) | 3.54501985 |
| 138 | lipid oxidation (GO:0034440) | 3.54248329 |
| 139 | sodium-independent organic anion transport (GO:0043252) | 3.48682662 |
| 140 | negative regulation of complement activation (GO:0045916) | 3.48567064 |
| 141 | acute inflammatory response (GO:0002526) | 3.43509575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31261539 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13202520 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.72951734 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.40594425 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.10777758 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94599437 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85462234 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97251896 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.86738138 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14750226 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11505220 |
| 12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05776036 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7514931 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63946336 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61016249 |
| 16 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45927627 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37640944 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29097448 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26329600 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16025761 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15875822 |
| 22 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12111390 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08480544 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08108774 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06172907 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05150860 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01275438 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00072015 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98289971 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96948676 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96137008 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94168137 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88194481 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86617395 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86136720 |
| 36 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.81653035 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81591021 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81044825 |
| 39 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80902505 |
| 40 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.79735253 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77309601 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76643363 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76550991 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75604144 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.74864157 |
| 46 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.74585721 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74557963 |
| 48 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74081363 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72677375 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72080388 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71890154 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71338134 |
| 53 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70730773 |
| 54 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70540812 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70527126 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70122717 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69391402 |
| 58 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.67663659 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.67433352 |
| 60 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.67263383 |
| 61 | NFYA_21822215_ChIP-Seq_K562_Human | 0.67001984 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66824721 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66824721 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65737221 |
| 65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64910193 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64720446 |
| 67 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64708131 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.63554673 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63128388 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62853868 |
| 71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.61266058 |
| 72 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61195816 |
| 73 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.60833975 |
| 74 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60113097 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59181329 |
| 76 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59101936 |
| 77 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.58977410 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.58680253 |
| 79 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58271424 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.58011225 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.57155045 |
| 82 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.55913220 |
| 83 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54940544 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54897589 |
| 85 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54456759 |
| 86 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.53400939 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53180546 |
| 88 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52874834 |
| 89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52779528 |
| 90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51960273 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.50521788 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.49965779 |
| 93 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49380069 |
| 94 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49135084 |
| 95 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48928385 |
| 96 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.48912363 |
| 97 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.48735102 |
| 98 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.48391460 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.47459932 |
| 100 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.47272107 |
| 101 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.47036574 |
| 102 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.46990281 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46862668 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.46821414 |
| 105 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.46353699 |
| 106 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.46135773 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45837161 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45768551 |
| 109 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.45584210 |
| 110 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45537266 |
| 111 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44750446 |
| 112 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44257897 |
| 113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43953208 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43162105 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42632789 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42420513 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42031149 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.41809971 |
| 119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.41091173 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40433112 |
| 121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39859237 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39248942 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38551086 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38492276 |
| 125 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.38059041 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37809711 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.37546229 |
| 128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.37512024 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37209758 |
| 130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37007150 |
| 131 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36867445 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.36827480 |
| 133 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.36414803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.99644682 |
| 2 | * MP0002139_abnormal_hepatobiliary_system | 7.60669831 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.29044493 |
| 4 | MP0005365_abnormal_bile_salt | 6.07517382 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.90946638 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.12034606 |
| 7 | MP0003252_abnormal_bile_duct | 3.97016029 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.43539056 |
| 9 | MP0005332_abnormal_amino_acid | 3.20397979 |
| 10 | MP0003195_calcinosis | 3.10518457 |
| 11 | MP0009840_abnormal_foam_cell | 3.05942477 |
| 12 | MP0005083_abnormal_biliary_tract | 2.84835749 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.61425717 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.61284052 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.26215058 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.24866801 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.07480612 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.06677738 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.89900004 |
| 20 | MP0003868_abnormal_feces_composition | 1.81258107 |
| 21 | MP0001764_abnormal_homeostasis | 1.69454721 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.66896195 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66738536 |
| 24 | MP0005451_abnormal_body_composition | 1.58137938 |
| 25 | MP0003186_abnormal_redox_activity | 1.41810559 |
| 26 | MP0009697_abnormal_copulation | 1.33478103 |
| 27 | MP0005636_abnormal_mineral_homeostasis | 1.28554428 |
| 28 | MP0003011_delayed_dark_adaptation | 1.21448066 |
| 29 | MP0005647_abnormal_sex_gland | 1.16015933 |
| 30 | MP0000598_abnormal_liver_morphology | 1.15322800 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.14234598 |
| 32 | MP0009764_decreased_sensitivity_to | 1.12924267 |
| 33 | MP0002132_abnormal_respiratory_system | 1.11335599 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.11114671 |
| 35 | MP0000604_amyloidosis | 1.01228512 |
| 36 | MP0004043_abnormal_pH_regulation | 0.99031775 |
| 37 | MP0001756_abnormal_urination | 0.98745133 |
| 38 | MP0009763_increased_sensitivity_to | 0.94411558 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 0.93039347 |
| 40 | MP0002876_abnormal_thyroid_physiology | 0.92663860 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.90873822 |
| 42 | MP0008469_abnormal_protein_level | 0.89549267 |
| 43 | MP0001915_intracranial_hemorrhage | 0.88405179 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.85988745 |
| 45 | MP0002254_reproductive_system_inflammat | 0.85654862 |
| 46 | MP0005408_hypopigmentation | 0.84790159 |
| 47 | MP0005670_abnormal_white_adipose | 0.84524802 |
| 48 | MP0002136_abnormal_kidney_physiology | 0.80786942 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.79845924 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.77960511 |
| 51 | MP0005376_homeostasis/metabolism_phenot | 0.77005994 |
| 52 | MP0010368_abnormal_lymphatic_system | 0.76470946 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 0.75957088 |
| 54 | MP0005535_abnormal_body_temperature | 0.75242670 |
| 55 | MP0005187_abnormal_penis_morphology | 0.74629656 |
| 56 | MP0003879_abnormal_hair_cell | 0.72987251 |
| 57 | MP0009785_altered_susceptibility_to | 0.71798788 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.71335559 |
| 59 | MP0001661_extended_life_span | 0.70161699 |
| 60 | MP0002971_abnormal_brown_adipose | 0.68893467 |
| 61 | MP0001765_abnormal_ion_homeostasis | 0.66713896 |
| 62 | MP0005334_abnormal_fat_pad | 0.65501380 |
| 63 | MP0004130_abnormal_muscle_cell | 0.63164538 |
| 64 | MP0003329_amyloid_beta_deposits | 0.62582362 |
| 65 | MP0005023_abnormal_wound_healing | 0.61722196 |
| 66 | MP0005266_abnormal_metabolism | 0.61465403 |
| 67 | MP0003690_abnormal_glial_cell | 0.61244317 |
| 68 | MP0009053_abnormal_anal_canal | 0.60649068 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.60164266 |
| 70 | MP0002928_abnormal_bile_duct | 0.56066469 |
| 71 | MP0003638_abnormal_response/metabolism_ | 0.55530302 |
| 72 | MP0005395_other_phenotype | 0.52687003 |
| 73 | MP0002249_abnormal_larynx_morphology | 0.50286731 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.50057806 |
| 75 | MP0000639_abnormal_adrenal_gland | 0.49533162 |
| 76 | MP0005448_abnormal_energy_balance | 0.49076395 |
| 77 | MP0005164_abnormal_response_to | 0.47131332 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.46845441 |
| 79 | MP0000230_abnormal_systemic_arterial | 0.46247158 |
| 80 | MP0004883_abnormal_blood_vessel | 0.45542853 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.45457246 |
| 82 | MP0008874_decreased_physiological_sensi | 0.44859502 |
| 83 | MP0003953_abnormal_hormone_level | 0.43816128 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.43434713 |
| 85 | MP0002822_catalepsy | 0.43185289 |
| 86 | MP0008873_increased_physiological_sensi | 0.42656790 |
| 87 | MP0002168_other_aberrant_phenotype | 0.42634643 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.42482697 |
| 89 | MP0003718_maternal_effect | 0.42213559 |
| 90 | MP0005166_decreased_susceptibility_to | 0.41419594 |
| 91 | MP0002796_impaired_skin_barrier | 0.41103461 |
| 92 | MP0003075_altered_response_to | 0.40443308 |
| 93 | MP0008872_abnormal_physiological_respon | 0.40256181 |
| 94 | MP0003724_increased_susceptibility_to | 0.40033203 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.38323467 |
| 96 | MP0003300_gastrointestinal_ulcer | 0.37609544 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.37146647 |
| 98 | MP0001851_eye_inflammation | 0.37048065 |
| 99 | MP0009672_abnormal_birth_weight | 0.36082640 |
| 100 | MP0002135_abnormal_kidney_morphology | 0.34756892 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.34172407 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 0.33798827 |
| 103 | MP0003436_decreased_susceptibility_to | 0.32988455 |
| 104 | MP0005248_abnormal_Harderian_gland | 0.32851468 |
| 105 | MP0009115_abnormal_fat_cell | 0.30814751 |
| 106 | MP0002419_abnormal_innate_immunity | 0.30634225 |
| 107 | MP0006082_CNS_inflammation | 0.30394320 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.29749326 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.29654117 |
| 110 | MP0003959_abnormal_lean_body | 0.28405455 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.27469739 |
| 112 | MP0000249_abnormal_blood_vessel | 0.27332846 |
| 113 | MP0002970_abnormal_white_adipose | 0.26924581 |
| 114 | MP0000579_abnormal_nail_morphology | 0.26811435 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.26321242 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.26321242 |
| 117 | MP0004381_abnormal_hair_follicle | 0.26159768 |
| 118 | MP0003303_peritoneal_inflammation | 0.25554132 |
| 119 | MP0005025_abnormal_response_to | 0.24309178 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.22739549 |
| 121 | MP0004142_abnormal_muscle_tone | 0.19135272 |
| 122 | MP0000920_abnormal_myelination | 0.19003098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.14676842 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.88109607 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.74605171 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.27763739 |
| 5 | Xanthomatosis (HP:0000991) | 5.96231733 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.87778567 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.84705400 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.11293204 |
| 9 | Complement deficiency (HP:0004431) | 4.79498027 |
| 10 | Hyperammonemia (HP:0001987) | 4.66451696 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.65855737 |
| 12 | Hyperglycinemia (HP:0002154) | 4.57321207 |
| 13 | Hyperglycinuria (HP:0003108) | 4.53792627 |
| 14 | Ketosis (HP:0001946) | 4.51397481 |
| 15 | Joint hemorrhage (HP:0005261) | 4.39456918 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.34918007 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.34918007 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.33706018 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28700818 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.26401041 |
| 21 | Epidermoid cyst (HP:0200040) | 4.12418493 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.02272819 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.95849168 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.94808471 |
| 25 | Fat malabsorption (HP:0002630) | 3.93284168 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.77093828 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.76846923 |
| 28 | Nephritis (HP:0000123) | 3.74525765 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64819909 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.63471715 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.51914976 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.47062787 |
| 33 | Gout (HP:0001997) | 3.46556533 |
| 34 | Abnormality of complement system (HP:0005339) | 3.45916965 |
| 35 | Ketoacidosis (HP:0001993) | 3.45469346 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.39714475 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.32639037 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30688592 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.27835855 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.26919449 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.19952839 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.10522531 |
| 43 | Metabolic acidosis (HP:0001942) | 2.97612923 |
| 44 | Steatorrhea (HP:0002570) | 2.96343767 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.95028735 |
| 46 | Vascular calcification (HP:0004934) | 2.83400052 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82483626 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.82483626 |
| 49 | Lethargy (HP:0001254) | 2.75630335 |
| 50 | Osteomalacia (HP:0002749) | 2.70121782 |
| 51 | Myocardial infarction (HP:0001658) | 2.67531147 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.65440806 |
| 53 | Spontaneous abortion (HP:0005268) | 2.62726504 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.57418761 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.55964683 |
| 56 | Purpura (HP:0000979) | 2.54792688 |
| 57 | Malnutrition (HP:0004395) | 2.54003749 |
| 58 | Alkalosis (HP:0001948) | 2.53445214 |
| 59 | Neonatal hypoglycemia (HP:0001998) | 2.53381065 |
| 60 | Fair hair (HP:0002286) | 2.52810743 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.52747107 |
| 62 | Skin nodule (HP:0200036) | 2.51956472 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.51161747 |
| 64 | Spastic diplegia (HP:0001264) | 2.50843931 |
| 65 | Irritability (HP:0000737) | 2.45584189 |
| 66 | Pulmonary embolism (HP:0002204) | 2.45164155 |
| 67 | Hyperuricemia (HP:0002149) | 2.43489433 |
| 68 | Increased purine levels (HP:0004368) | 2.43489433 |
| 69 | Neonatal onset (HP:0003623) | 2.43279717 |
| 70 | Cerebral edema (HP:0002181) | 2.42353050 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.32136348 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.32136348 |
| 73 | Sensorimotor neuropathy (HP:0007141) | 2.31916583 |
| 74 | Vomiting (HP:0002013) | 2.31418258 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 2.31286074 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.31257293 |
| 77 | Enlarged kidneys (HP:0000105) | 2.30044957 |
| 78 | Rickets (HP:0002748) | 2.25931272 |
| 79 | Mitral stenosis (HP:0001718) | 2.25909551 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.25173016 |
| 81 | Late onset (HP:0003584) | 2.22295145 |
| 82 | Acanthocytosis (HP:0001927) | 2.21291721 |
| 83 | Cholelithiasis (HP:0001081) | 2.20952642 |
| 84 | Glomerulonephritis (HP:0000099) | 2.19544718 |
| 85 | Pancreatitis (HP:0001733) | 2.18938508 |
| 86 | Glycosuria (HP:0003076) | 2.18934254 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 2.18934254 |
| 88 | Abnormal gallbladder physiology (HP:0012438) | 2.18058605 |
| 89 | Cholecystitis (HP:0001082) | 2.18058605 |
| 90 | Hyperphosphaturia (HP:0003109) | 2.13229749 |
| 91 | Esophageal varix (HP:0002040) | 2.08968699 |
| 92 | Elevated alkaline phosphatase (HP:0003155) | 2.06625082 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06338060 |
| 94 | Brushfield spots (HP:0001088) | 2.06019555 |
| 95 | Abnormality of vitamin metabolism (HP:0100508) | 2.05947878 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01753765 |
| 97 | Opisthotonus (HP:0002179) | 2.01074947 |
| 98 | Amyloidosis (HP:0011034) | 1.99428429 |
| 99 | Hypophosphatemic rickets (HP:0004912) | 1.98894722 |
| 100 | Arthropathy (HP:0003040) | 1.98848189 |
| 101 | Menorrhagia (HP:0000132) | 1.98062169 |
| 102 | Increased mean platelet volume (HP:0011877) | 1.93739348 |
| 103 | Thrombophlebitis (HP:0004418) | 1.93494100 |
| 104 | Bifid scrotum (HP:0000048) | 1.92714468 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.91821658 |
| 106 | Gangrene (HP:0100758) | 1.90975142 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 1.90787418 |
| 108 | Increased serum ferritin (HP:0003281) | 1.90512075 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 1.90338770 |
| 110 | Abnormality of the gallbladder (HP:0005264) | 1.89288118 |
| 111 | Joint swelling (HP:0001386) | 1.88314452 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.86226329 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85834707 |
| 114 | Gingival bleeding (HP:0000225) | 1.83878295 |
| 115 | Renal cortical cysts (HP:0000803) | 1.82978327 |
| 116 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82596768 |
| 117 | Nephrolithiasis (HP:0000787) | 1.82155234 |
| 118 | Status epilepticus (HP:0002133) | 1.81376439 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.79536208 |
| 120 | Generalized hypopigmentation of hair (HP:0011358) | 1.76929911 |
| 121 | Poikilocytosis (HP:0004447) | 1.76414619 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74473962 |
| 123 | Abnormal urine phosphate concentration (HP:0012599) | 1.70606496 |
| 124 | Epistaxis (HP:0000421) | 1.69886478 |
| 125 | Impaired platelet aggregation (HP:0003540) | 1.66225583 |
| 126 | Abnormal platelet function (HP:0011869) | 1.66225583 |
| 127 | Bile duct proliferation (HP:0001408) | 1.65448629 |
| 128 | Abnormal biliary tract physiology (HP:0012439) | 1.65448629 |
| 129 | Hypochromic anemia (HP:0001931) | 1.62381185 |
| 130 | Atrioventricular block (HP:0001678) | 1.62330220 |
| 131 | Reticulocytosis (HP:0001923) | 1.53268299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.38569873 |
| 2 | ERN1 | 4.37333367 |
| 3 | FGFR4 | 4.26741500 |
| 4 | SIK1 | 4.11461436 |
| 5 | TAOK3 | 2.81891585 |
| 6 | INSRR | 2.69522689 |
| 7 | PRPF4B | 2.57181679 |
| 8 | ERBB4 | 2.51497481 |
| 9 | MST1R | 2.25265315 |
| 10 | NTRK3 | 2.25156744 |
| 11 | MAP2K4 | 2.07150174 |
| 12 | WNK4 | 2.02845078 |
| 13 | PKN2 | 2.02540912 |
| 14 | PIK3CA | 1.96327167 |
| 15 | WNK3 | 1.94861463 |
| 16 | LATS1 | 1.75219915 |
| 17 | TRIB3 | 1.72729474 |
| 18 | MAPK11 | 1.72402874 |
| 19 | FRK | 1.69181164 |
| 20 | OXSR1 | 1.67607651 |
| 21 | FLT3 | 1.61511172 |
| 22 | PIK3CG | 1.61036114 |
| 23 | STK38L | 1.54808359 |
| 24 | TYK2 | 1.48960190 |
| 25 | PTK6 | 1.46696043 |
| 26 | ABL2 | 1.43490073 |
| 27 | TNK2 | 1.37503317 |
| 28 | MAP3K12 | 1.31774754 |
| 29 | DAPK2 | 1.26842479 |
| 30 | PINK1 | 1.26569489 |
| 31 | MAP3K7 | 1.25695156 |
| 32 | MAP3K1 | 1.22764536 |
| 33 | NEK9 | 1.20769263 |
| 34 | NLK | 1.17218630 |
| 35 | GRK6 | 1.16477203 |
| 36 | FGFR2 | 1.13921184 |
| 37 | JAK2 | 1.11674451 |
| 38 | KDR | 1.08590223 |
| 39 | PRKAA2 | 1.08462569 |
| 40 | MAP2K3 | 1.02627043 |
| 41 | MAP3K3 | 0.98547812 |
| 42 | KSR2 | 0.93436055 |
| 43 | FER | 0.92819450 |
| 44 | MAP3K14 | 0.92695430 |
| 45 | MYLK | 0.91940379 |
| 46 | EPHB1 | 0.91734259 |
| 47 | TBK1 | 0.91354052 |
| 48 | BLK | 0.90606068 |
| 49 | PRKCZ | 0.89605535 |
| 50 | ZAP70 | 0.87793444 |
| 51 | PRKG1 | 0.86858981 |
| 52 | MET | 0.86388257 |
| 53 | ERBB2 | 0.86087846 |
| 54 | JAK1 | 0.85089480 |
| 55 | MAPK4 | 0.83264718 |
| 56 | SGK3 | 0.81056034 |
| 57 | PDK4 | 0.79853196 |
| 58 | PDK3 | 0.79853196 |
| 59 | TIE1 | 0.79794840 |
| 60 | MAP3K10 | 0.78629081 |
| 61 | GSK3A | 0.78023546 |
| 62 | MAPK15 | 0.77061770 |
| 63 | SGK494 | 0.76494992 |
| 64 | SGK223 | 0.76494992 |
| 65 | PRKACA | 0.74617459 |
| 66 | DYRK1B | 0.73575775 |
| 67 | PRKAA1 | 0.72994591 |
| 68 | MAP3K11 | 0.72328443 |
| 69 | MAPK12 | 0.70915960 |
| 70 | PRKACG | 0.69519208 |
| 71 | MAP2K6 | 0.65410716 |
| 72 | PTK2 | 0.65155823 |
| 73 | STK39 | 0.65042618 |
| 74 | SGK2 | 0.64965855 |
| 75 | CAMKK2 | 0.64189151 |
| 76 | IRAK3 | 0.63825923 |
| 77 | CDK6 | 0.63641010 |
| 78 | IRAK1 | 0.62934672 |
| 79 | CSK | 0.61062988 |
| 80 | TGFBR2 | 0.60916129 |
| 81 | RIPK1 | 0.60878656 |
| 82 | CAMK2G | 0.60432279 |
| 83 | PDPK1 | 0.59024841 |
| 84 | ARAF | 0.58197344 |
| 85 | CSNK1D | 0.51869156 |
| 86 | PRKCB | 0.51060491 |
| 87 | MUSK | 0.50015815 |
| 88 | CAMK1D | 0.48431740 |
| 89 | PRKCQ | 0.47864993 |
| 90 | EPHA3 | 0.47379596 |
| 91 | PDK2 | 0.46622826 |
| 92 | NEK1 | 0.46218207 |
| 93 | RPS6KA3 | 0.45746027 |
| 94 | SGK1 | 0.45288292 |
| 95 | AKT3 | 0.43683674 |
| 96 | CSF1R | 0.42878724 |
| 97 | MAPK7 | 0.42815492 |
| 98 | TAOK1 | 0.42708014 |
| 99 | IKBKE | 0.41875906 |
| 100 | FGFR3 | 0.41839870 |
| 101 | STK38 | 0.38203072 |
| 102 | CSNK1G1 | 0.38141423 |
| 103 | CHUK | 0.38122834 |
| 104 | GRK1 | 0.38080417 |
| 105 | PDK1 | 0.37360440 |
| 106 | IGF1R | 0.37025740 |
| 107 | IKBKB | 0.36760535 |
| 108 | SRC | 0.36626140 |
| 109 | JAK3 | 0.36495732 |
| 110 | EPHA4 | 0.36064444 |
| 111 | PIM2 | 0.35767945 |
| 112 | MAP2K1 | 0.35655128 |
| 113 | MAP3K5 | 0.34430822 |
| 114 | PRKACB | 0.33117317 |
| 115 | STK16 | 0.32582927 |
| 116 | MTOR | 0.32207111 |
| 117 | ICK | 0.32162688 |
| 118 | TAOK2 | 0.31932593 |
| 119 | RET | 0.31505409 |
| 120 | PRKCG | 0.31108964 |
| 121 | IRAK2 | 0.29665102 |
| 122 | MAP2K2 | 0.29271983 |
| 123 | MAP4K1 | 0.29059273 |
| 124 | MAP3K13 | 0.28261469 |
| 125 | CAMKK1 | 0.28071903 |
| 126 | EGFR | 0.27199197 |
| 127 | MAP3K2 | 0.27154051 |
| 128 | MAP3K6 | 0.26635721 |
| 129 | PRKCA | 0.26452040 |
| 130 | CAMK4 | 0.26020296 |
| 131 | CDK4 | 0.24615711 |
| 132 | PAK3 | 0.23662644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26276945 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49778929 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33051083 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24942712 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92392293 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74491408 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72990042 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64671309 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55404992 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55092733 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50802693 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45463167 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42711749 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37709028 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.18183233 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11228690 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09802459 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89328634 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87979751 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87766776 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87306307 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85339316 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85058162 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84242058 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78367656 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70941105 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70420623 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68523068 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66151888 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64985738 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64459206 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55398334 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52172025 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51567511 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50165934 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50011896 |
| 37 | * Bile secretion_Homo sapiens_hsa04976 | 1.47533246 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34159294 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33650925 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31943611 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31605215 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29910613 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27158685 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22791075 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21516436 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19829287 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14965282 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13619457 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.12785676 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09939140 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07284743 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04973015 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01277690 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97824188 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92859656 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91135959 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.88400267 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81880268 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81298988 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78929495 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77133434 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72573397 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70829240 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67189941 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59680058 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48539574 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42796135 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35096780 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.33883628 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30794684 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.25657391 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25498984 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24216989 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.21821043 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20621491 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20577292 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17621154 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11632537 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07531284 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07107580 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01946859 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2828736 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2558467 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2422424 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2241247 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2108133 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2050938 |
| 88 | Lysosome_Homo sapiens_hsa04142 | -0.2043758 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1969554 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1886683 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1818838 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1809270 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1693994 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1584509 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1358059 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1351923 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1350508 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | -0.1330881 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1256790 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1222498 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1071390 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1054990 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0983047 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0843922 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0778254 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0433726 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0149418 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | -0.0137073 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0097460 |

